Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

First Wave BioPharma, Inc. (AZRX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  20.80.00.00.00.0-1.0-8.0-1.2
            Revenue growth      -100.0%-87.3%563.1% 
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  20.80.00.00.00.0-1.0-8.0-1.2
            Gross margin  100.0%    100.0%100.0%100.0%
Selling, general and administrative   [+]12.018.47.36.17.57.74.13.3
Research and development  8.817.05.98.75.82.42.51.4
Other operating expenses  12.721.313.3 0.2-0.9-8.3-1.2
EBITDA   [+]-12.6-56.2-25.9-13.7-12.6-9.5-5.6-4.0
            EBITDA margin  -60.9%    932.5%70.2%332.5%
Depreciation  0.00.00.00.20.10.00.00.0
EBITA  -12.7-56.2-25.9-14.0-12.7-9.5-5.6-4.0
            EBITA margin  -61.1%    937.4%70.7%336.0%
Amortization of intangibles   0.50.50.80.70.70.70.7
EBIT   [+]-12.7-56.7-26.4-14.7-13.4-10.2-6.3-4.7
            EBIT margin  -61.1%    1006.8%79.4%393.6%
Non-recurring items   [+] 2.4      
Interest expense, net   [+]0.00.05.80.40.10.95.91.6
Other income (expense), net   [+]-1.90.5-0.4   -2.30.4
Pre-tax income  -14.6-58.5-32.7-15.2-13.5-11.1-14.6-5.9
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -15.0-84.5-41.7-15.2-13.5-11.1-14.6-5.9
            Net margin  -72.1%    1093.0%183.2%493.6%
   
Basic EPS   [+]($20.85)($1,988.53)($36,288,989.57)($22,320,126.47)$15,379,110.23($1.04)($2.24)($1.63)
Diluted EPS   [+]($20.85)($1,988.53)($36,288,989.57)($22,320,126.47)$15,379,110.23($1.04)($2.24)($1.63)
   
Shares outstanding (basic)   [+]0.70.00.00.00.010.66.53.6
Shares outstanding (diluted)   [+]0.70.00.00.00.010.66.53.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy